KRAS: the critical driver and therapeutic target for pancreatic cancer

AM Waters, CJ Der - Cold Spring Harbor …, 2018 - perspectivesinmedicine.cshlp.org
RAS genes (HRAS, KRAS, and NRAS) comprise the most frequently mutated oncogene
family in human cancer. With the highest RAS mutation frequencies seen with the top three …

RAS isoforms and mutations in cancer at a glance

GA Hobbs, CJ Der, KL Rossman - Journal of cell science, 2016 - journals.biologists.com
ABSTRACT RAS proteins (KRAS4A, KRAS4B, NRAS and HRAS) function as GDP–GTP-
regulated binary on-off switches, which regulate cytoplasmic signaling networks that control …

Drugging the undruggable RAS: Mission possible?

AD Cox, SW Fesik, AC Kimmelman, J Luo… - Nature reviews Drug …, 2014 - nature.com
Despite more than three decades of intensive effort, no effective pharmacological inhibitors
of the RAS oncoproteins have reached the clinic, prompting the widely held perception that …

Dragging ras back in the ring

AG Stephen, D Esposito, RK Bagni, F McCormick - Cancer cell, 2014 - cell.com
Ras proteins play a major role in human cancers but have not yielded to therapeutic attack.
Ras-driven cancers are among the most difficult to treat and often excluded from therapies …

Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery

CE Paulsen, KS Carroll - Chemical reviews, 2013 - ACS Publications
Reactive oxygen, nitrogen, and sulfur species, referred to as ROS, RNS, and RSS,
respectively, are produced during normal cell function and in response to various stimuli. An …

An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications

RA Dweik, PB Boggs, SC Erzurum, CG Irvin… - American journal of …, 2011 - atsjournals.org
Background: Measurement of fractional nitric oxide (NO) concentration in exhaled breath
(FeNO) is a quantitative, noninvasive, simple, and safe method of measuring airway …

RAS interaction with PI3K: more than just another effector pathway

E Castellano, J Downward - Genes & cancer, 2011 - journals.sagepub.com
RAS proteins are small GTPases known for their involvement in oncogenesis: around 25%
of human tumors present mutations in a member of this family. RAS operates in a complex …

Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells

N Charles, T Ozawa, M Squatrito, AM Bleau… - Cell stem cell, 2010 - cell.com
Summary eNOS expression is elevated in human glioblastomas and correlated with
increased tumor growth and aggressive character. We investigated the potential role of nitric …

Protein S-nitrosylation in health and disease: a current perspective

MW Foster, DT Hess, JS Stamler - Trends in molecular medicine, 2009 - cell.com
Protein S-nitrosylation constitutes a large part of the ubiquitous influence of nitric oxide on
cellular signal transduction and accumulating evidence indicates important roles for S …

In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras–effector interaction

F Shima, Y Yoshikawa, M Ye, M Araki… - Proceedings of the …, 2013 - National Acad Sciences
Mutational activation of the Ras oncogene products (H-Ras, K-Ras, and N-Ras) is frequently
observed in human cancers, making them promising anticancer drug targets. Nonetheless …